Tag: FDA Orange Book
Paragraph IV Certifications: How Generic Drugs Challenge Patents Early
Paragraph IV certifications let generic drug makers challenge brand patents before launch, saving consumers billions. This legal tool under the Hatch-Waxman Act drives competition, lowers prices, and reshapes the U.S. drug market.
Continue ReadingPopular Posts
-
-
-
-
-
When Your Doctor Might Prescribe Brand-Name Only and Why
23 March 2026